The French National Research Agency Projects for science

Voir cette page en français

ANR funded project

Laboratoires communs organismes de recherche publics – PME/ETI (LabCom V6) 2014
Projet OncoTrail

Development of Cellular, Tissular and Animal models in oncology

"The Research Unit ""UMS BIOSIT"" and the company ""BIOTRIAL"" have plans to create a Joint Research Laboratory on the understanding and development of cell, tissue and animal cancer models. This project is built on over 10 years of collaboration between BIOTRIAL and research teams and academic technology platforms from Rennes.
The UMS (University of Rennes 1/INSERM/CNRS) ""BIOSIT"" brings together all the research teams in Biology - Health in Rennes (45 teams) around a common scientific strategy. BIOSIT gathers the material, financial and human resources to optimize the management of 14 technology platforms and supports research projects in specific themes. Among the 6 unifying themes gathering the scientific activities of the different teams of BIOSIT, the axis of cancer research plays a major role. The theme ""signalling and cancer"" focuses on the relationship between basic research and clinical research. In this context, a new scientific dynamic has emerged over the past two years between BIOSIT and BIOTRIAL (Contract Research Organization) whose mission is to conduct clinical and preclinical product evaluations oriented in health or nutrition. Indeed, beyond its clinical research activities and facing an increasing demand from its French and international clients, BIOTRIAL is now developing preclinical activities in cancer research, to support pharmaceutical companies or biotechnology throughout the development of their molecules.
About the Joint Laboratory: BIOTRIAL wants to strengthen its links with academic research teams in Rennes and technological platforms through BIOSIT. The creation of a Joint Laboratory will therefore enable the company to benefit from the scientific expertise in oncology of academic researchers but will also allow the company and university laboratories to set up together and for common projects, different cell, tissue and innovative animals models that will enable to evaluate new therapeutic targets and to generate new useful and necessary tools to a better understanding of these diseases at a fundamental and translational levels. BIOTRIAL on its side is recognized in France and internationally for its sales force that will benefit to the Joint Laboratory. Cancer types identified at first are those that Rennes has clinical, biological and research expertise and has human biological samples collections, but also a biobank of canine samples. Under these conditions, the creation of a Joint Laboratory through a real bilateral partnership around the theme of preclinical cancer research is the ideal structure to meet the needs of researchers from BIOSIT and BIOTRIAL.
Research links already exist between the two partners through the access to the technological platforms and first exchange of biological material and know-how. However today, BIOSIT and BIOTRIAL want to strengthened these relationships through a lot more formal and structured Joint Laboratory to develop a laboratory of excellence with an international visibility contributing, in particular through the development of new unique biological models, to therapeutic innovation in oncology. The Joint Laboratory will not have its own legal personality and therefore BIOSIT and BIOTRIAL will make available to the Joint Laboratory all the means necessary for the implementation of projects that will be assigned, including appropriate materials and technical equipment as well as personal with relevant knowledge and useful expertise."



ANR grant: 300 000 euros
Beginning and duration: janvier 2015 - 36 mois


ANR Programme: Laboratoires communs organismes de recherche publics – PME/ETI (LabCom V6) 2014

Project ID: ANR-14-LAB6-0004

Project coordinator:


Back to the previous page


The project coordinator is the author of this abstract and is therefore responsible for the content of the summary. The ANR disclaims all responsibility in connection with its content.